- Investing Ideas
- Danish Pharmaceuticals & Biotech Healthy potentially undervalued
Danish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
4
Companies which are potentially undervalued and in an acceptable financial position.
4 companies
Bavarian Nordic
Market Cap: DKK 14.8b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 192.00
7D
4.7%
1Y
21.8%
H. Lundbeck
Market Cap: DKK 37.2b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 38.72
7D
4.3%
1Y
6.6%
Novo Nordisk
Market Cap: DKK 1.1t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 238.45
7D
0.2%
1Y
-50.4%
ChemoMetec
Market Cap: DKK 5.2b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 297.00
7D
-24.7%
1Y
-41.0%